-
1دورية أكاديمية
المؤلفون: Vasilopoulos, Y., Bagiatis, V., Stamatopoulou, D., Zisopoulos, D., Alexiou, I., Sarafidou, T., Settas, L., Sakkas, L., Mamuris, Z.
مصطلحات موضوعية: Anti-CCP, Anti-TNF, Association, Pharmacogenetics, Polymorphism, adalimumab, cyclic citrullinated peptide antibody, etanercept, infliximab, leflunomide, methotrexate, rheumatoid factor, tumor necrosis factor inhibitor, antirheumatic agent, autoantibody, biological marker, cyclic citrullinated peptide, cyclopeptide, TNFRSF1A protein, human, TNFRSF1B protein, tumor necrosis factor alpha, tumor necrosis factor receptor 1, tumor necrosis factor receptor 2, adult, aged, allele, article, cohort analysis, controlled study
-
2دورية أكاديمية
المؤلفون: Vasilopoulos, Y., Bagiatis, V., Stamatopoulou, D., Zisopoulos, D., Alexiou, I., Sarafidou, T., Settas, L., Sakkas, L., Mamuris, Z.
المصدر: Clinical and Experimental Rheumatology ; ://WOS:000295351900015
مصطلحات موضوعية: pharmacogenetics, anti-TNF, association, anti-CCP, polymorphism, TUMOR-NECROSIS-FACTOR, GENE POLYMORPHISM, FUTURE-DIRECTIONS, THERAPY, DISEASE, POSITION-308, VALIDATION, INFLIXIMAB, ANTIBODIES, Rheumatology